FIMECS, Inc.
PrivateLast Round
M&A
Feb 14, 2024
Total Funding Raised
$19.94M
Company Overview
FIMECS, Inc. operates in Healthcare & Life Sciences and is based in Fujisawa. Its latest recorded funding round was a Series B round in January 2022.
FIMECS, Inc. is a drug discovery company that develops therapeutics based on targeted protein degradation for previously 'undruggable' targets using its proprietary RaPPIDS™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FIMECS, Inc. Comparables
Compare FIMECS, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beactica Therapeutics | 84% | |
| Cullgen | 83% | |
| Pin Therapeutics | 82% |
For institutional investors. Book with your work email.
FIMECS, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Feb 14, 2024 | ||||
| Series B | Jan 24, 2022 | ||||
| Grant | Aug 18, 2021 | ||||
| Series A | May 28, 2020 | ||||
| Seed | Dec 1, 2019 | ||||
Seed | Mar 1, 2018 |
For institutional investors. Book with your work email.
FIMECS, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Energy and Industrial Technology Development Organization | Grant |
| Nissay Capital | Series B |
| ANRI株式会社 | Series A, Series B |
| Kyoto University Innovation Capital | Series B, Series A |
| UTokyo Innovation Platform Co., Ltd. | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 45% MoM.
- Feb 14, 2024
$30M round led by RaQualia Pharma, Inc.
For institutional investors. Book with your work email.
FIMECS, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FIMECS, Inc.'s valuation, stock price, and market status.
Is FIMECS, Inc. a public or private company?
FIMECS, Inc. is a private company.
What is the current stock price of FIMECS, Inc.?
FIMECS, Inc. is a private company, so its shares have no public market price. Caplight tracks FIMECS, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FIMECS, Inc. worth (valuation)?
Valuation information for FIMECS, Inc. is not publicly available.
Can I buy FIMECS, Inc. stock?
FIMECS, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FIMECS, Inc.'s last funding round?
FIMECS, Inc.'s most recent funding round was M&A on February 14, 2024.
Who are the main investors in FIMECS, Inc.?
Key investors in FIMECS, Inc. include Nissay Capital, Kyoto University Innovation Capital, UTokyo Innovation Platform Co., Ltd..
Will FIMECS, Inc. IPO soon?
No public IPO plans have been announced for FIMECS, Inc..
How can I track FIMECS, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in FIMECS, Inc.'s shares on secondary markets.